Acute cardiovascular and sympathetic effects of nicotine replacement therapy

Hypertension

Volumn 47, Issue 6, 2006, Pages 1162-1167

  Najem, Boutaïna ^a   Houssière, Anne ^b   Pathak, Atul ^a   Janssen, Christophe ^a   Lemogoum, Daniel ^a   Xhaët, Olivier ^a   Cuylits, Nicolas ^a   Van De Borne, Philippe ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Chemoreceptors; Smoking; Sympathetic nervous system

Indexed keywords

NICOTINE; OXYGEN; NICOTINIC AGENT;

ADULT; APNEA; ARTICLE; BLOOD PRESSURE; CHEMORECEPTOR; CHEMORECEPTOR REFLEX; CONTROLLED STUDY; FEMALE; HEART RATE; HUMAN; HYPOXIA; LUNG MINUTE VOLUME; MALE; MUSCLE BLOOD FLOW; NICOTINE REPLACEMENT THERAPY; NORMAL HUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZATION; SMOKING; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE; ADRENERGIC SYSTEM; ANOXIA; BREATHING; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; INNERVATION; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE;

ADULT; ANOXIA; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; MALE; MUSCLE, SKELETAL; NICOTINE; NICOTINIC AGONISTS; RESPIRATION; SYMPATHETIC NERVOUS SYSTEM;

EID: 33744966152     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000219284.47970.34     Document Type: Article

References (42)

1. Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med. 1986;314:271-275.
2. Willett WC, Green A, Stampfer MJ, Speizer FE, Colditz GA, Rosner B, Monson RR, Stason W, Hennekens CH. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med. 1987;317:1303-1309.
3. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43:1731-1737.
4. Narkiewicz K, van de Borne PJ, Hausberg M, Cooley RL, Winniford MD, Davison DE, Somers VK. Cigarette smoking increases sympathetic outflow in humans. Circulation. 1998;98:528-534.
5. Niedermaier ON, Smith ML, Beightol LA, Zukowska-Grojec Z, Goldstein DS, Eckberg DL. Influence of cigarette smoking on human autonomic function. Circulation. 1993;88:562-571.
6. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 1976;295:573-577.
7. Winniford MD, Wheelan KR, Kremers MS, Ugolini V, Van den Berg E Jr, Niggemann EH, Jansen DE, Hillis LD. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. Circulation. 1986;73:662-667.
8. Benowitz NL. The role of nicotine in smoking-related cardiovascular disease. Prev Med. 1997;26:412-417.
9. Benowitz NL. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med. 1988;319:1318-1330.
10. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol. 1997;29:1422-1431.
11. Henningfield JE. Nicotine medications for smoking cessation. N Engl J Med. 1995;333:1196-1203.
12. Gray N, Boyle P. The future of the nicotine-addiction market. Lancet. 2003;362:845-846.
13. Gonzalez C, Almaraz L, Obeso A, Rigual R. Carotid body chemoreceptors: from natural stimuli to sensory discharges. Physiol Rev. 1994;74:829-898.
14. Lugliani R, Whipp BJ, Seard C, Wasserman K. Effect of bilateral carotid-body resection on ventilatory control at rest and during exercise in man. N Engl J Med. 1971;285:1105-1111.
15. Ciarka A, Najem B, Cuylits N, Leeman M, Xhaet O, Narkiewicz K, Antoine M, Degaute JP, van de Borne P. Effects of peripheral chemoreceptors deactivation on sympathetic activity in heart transplant recipients. Hypertension. 2005;45:894-900.
16. Balfour DJ. The effects of nicotine on brain neurotransmitter systems. Pharmacol Ther. 1982;16:269-282.
17. Nedergaard OA, Schrold J. The mechanism of action of nicotine on vascular adrenergic neuroeffector transmission. Eur J Pharmacol. 1977;42:315-329.
18. Dinger B, Gonzalez C, Yoshizaki K, Fidone S. Localization and function of cat carotid body nicotinic receptors. Brain Res. 1985;339:295-304.
19. Hayashida Y, Eyzaguirre C. Voltage noise of carotid body type I cells. Brain Res. 1979;167:189-194.
20. Obeso A, Gomez-Nino MA, Almaraz L, Dinger B, Fidone S, Gonzalez C. Evidence for two types of nicotinic receptors in the cat carotid body chemoreceptor cells. Brain Res. 1997;754:298-302.
21. Holgert H, Hokfelt T, Hertzberg T, Holgert H. Functional and developmental studies of the peripheral arterial chemoreceptors in rat: effects of nicotine and possible relation to sudden infant death syndrome. Proc Natl Acad Sci U S A. 1995;92:7575-7579.
22. Lee LY, Morton RF, Frazier DT. Influence of nicotine in cigarette smoke on acute ventilatory responses in awake dogs. J Appl Physiol. 1985;59:229-236.
23. Sasaki M, Yamaya M, Hida W, Nakamura M, Sasaki T, Sasaki H, Takishima T. Effect of hypercapnia on ventilatory response to intravenous nicotine administration in anesthetized dogs. Respir Physiol. 1989;78:177-186.
24. Fernandez R, Larrain C, Zapata P. Acute ventilatory and circulatory reactions evoked by nicotine: are they excitatory or depressant? Respir Physiol Neurobiol. 2002;133:173-182.
25. Kopczynska B, Szereda-Przestaszewska M. Response of respiratory muscles to intravenous nicotine challenge in anaesthetized cats. Respir Physiol. 1999;116:145-157.
26. Szereda-Przestaszewska M, Kopczynska B, Kaczynska K, Chrapusta SJ. Diverging respiratory effects of serotonin and nicotine in vagotomised cats prior to and after section of carotid sinus nerves. J Physiol Pharmacol. 2001;52:71-79.
27. Hirano T, Dinger B, Yoshizaki K, Gonzalez C, Fidone S. Nicotinic versus muscarinic binding sites in cat and rabbit carotid bodies. Biol Signals. 1992;1:143-149.
28. Sepkovic DW, Haley NJ. Biochemical applications of cotinine quantitation in smoking related research. Am J Public Health. 1985;75:663-665.
29. Gobel FL, Norstrom LA, Nelson RR, Jorgensen CR, Wang Y. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation. 1978;57:549-556.
30. Esler M. Sympathetic nervous system: contribution to human hypertension and related cardiovascular diseases. J Cardiovasc Pharmacol. 1995;26(suppl 2):S24-S28.
31. Podrid PJ, Fuchs T, Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation. 1990;82:I103-I113.
32. Seals DR, Dinenno FA. Collateral damage: cardiovascular consequences of chronic sympathetic activation with human aging. Am J Physiol Heart Circ Physiol. 2004;287:H1895-H1905.
33. LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, Curb JD, Evans D, Hennekens CH. Smoking and mortality among older men and women in three communities. N Engl J Med. 1991;324:1619-1625.
34. Minami J, Ishimitsu T, Matsuoka H. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension. 1999;33:586-590.
35. Kruger C, Haunstetter A, Gerber S, Serf C, Kaufmann A, Kubler W, Haass M. Nicotine-induced exocytotic norepinephrine release in guinea-pig heart, human atrium and bovine adrenal chromaffin cells: modulation by single components of ischaemia. J Mol Cell Cardiol. 1995;27:1491-1506.
36. Francis GS, Goldsmith SR, Ziesche S, Nakajima H, Cohn JN. Relative attenuation of sympathetic drive during exercise in patients with congestive heart failure. J Am Coll Cardiol. 1985;5:832-839.
37. Ng AV, Callister R, Johnson DG, Seals DR. Sympathetic neural reactivity to stress does not increase with age in healthy humans. Am J Physiol. 1994;267:H344-H353.
38. Casasola GG, Alvarez-Sala JL, Marques JA, Sanchez-Alarcos JM, Tashkin DP, Espinos D. Cigarette smoking behavior and respiratory alterations during sleep in a healthy population. Sleep Breath. 2002;6:19-24.
39. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165:1217-1239.
40. Shepard JW Jr, Garrison MW, Grither DA, Dolan GF. Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest. 1985;88:335-340.
41. Heistad DD, Abboud FM, Mark AL, Schmid PG. Interaction of baroreceptor and chemoreceptor reflexes. Modulation of the chemoreceptor reflex by changes in baroreceptor activity. J Clin Invest. 1974;53:1226-1236.
42. Hulihan-Giblin BA, Lumpkin MD, Kellar KJ. Effects of chronic administration of nicotine on prolactin release in the rat: inactivation of prolactin response by repeated injections of nicotine. J Pharmacol Exp Ther. 1990;252:21-25.